Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) FCF Margin (2024 - 2025)

Historic FCF Margin for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to 113.49%.

  • Kestra Medical Technologies' FCF Margin rose 394900.0% to 113.49% in Q4 2025 from the same period last year, while for Oct 2025 it was 152.91%, marking a year-over-year decrease of 86700.0%. This contributed to the annual value of 168.09% for FY2025, which is 1355700.0% up from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' FCF Margin is 113.49%, which was up 394900.0% from 177.79% recorded in Q3 2025.
  • Kestra Medical Technologies' FCF Margin's 5-year high stood at 113.49% during Q4 2025, with a 5-year trough of 191.96% in Q3 2024.